These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 34256650)
1. Targeting reactive nitroxidative species in preclinical models of migraine. Akerman S; Salvemini D; Romero-Reyes M Cephalalgia; 2021 Oct; 41(11-12):1187-1200. PubMed ID: 34256650 [TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite Contributes to Behavioral Responses, Increased Trigeminal Excitability, and Changes in Mitochondrial Function in a Preclinical Model of Migraine. Lackovic J; Jeevakumar V; Burton M; Price TJ; Dussor G J Neurosci; 2023 Mar; 43(9):1627-1642. PubMed ID: 36697259 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives. Akerman S; Romero-Reyes M; Karsan N; Bose P; Hoffmann JR; Holland PR; Goadsby PJ Pain; 2021 May; 162(5):1567-1577. PubMed ID: 33181579 [TBL] [Abstract][Full Text] [Related]
4. Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis. Akerman S; Romero-Reyes M J Cereb Blood Flow Metab; 2019 Apr; 39(4):704-717. PubMed ID: 28885085 [TBL] [Abstract][Full Text] [Related]
5. Vagus nerve stimulation suppresses acute noxious activation of trigeminocervical neurons in animal models of primary headache. Akerman S; Simon B; Romero-Reyes M Neurobiol Dis; 2017 Jun; 102():96-104. PubMed ID: 28286178 [TBL] [Abstract][Full Text] [Related]
8. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Olesen J Pharmacol Ther; 2008 Nov; 120(2):157-71. PubMed ID: 18789357 [TBL] [Abstract][Full Text] [Related]
9. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. De Felice M; Ossipov MH; Wang R; Dussor G; Lai J; Meng ID; Chichorro J; Andrews JS; Rakhit S; Maddaford S; Dodick D; Porreca F Brain; 2010 Aug; 133(Pt 8):2475-88. PubMed ID: 20627971 [TBL] [Abstract][Full Text] [Related]
10. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine. Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305 [TBL] [Abstract][Full Text] [Related]
11. Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain. Little JW; Doyle T; Salvemini D Amino Acids; 2012 Jan; 42(1):75-94. PubMed ID: 20552384 [TBL] [Abstract][Full Text] [Related]
12. Preclinical studies investigating the neural mechanisms involved in the co-morbidity of migraine and temporomandibular disorders: the role of CGRP. Akerman S; Romero-Reyes M Br J Pharmacol; 2020 Dec; 177(24):5555-5568. PubMed ID: 32929719 [TBL] [Abstract][Full Text] [Related]
14. PACAP-38 related modulation of the cranial parasympathetic projection: A novel mechanism and therapeutic target in severe primary headache. Akerman S; Goadsby PJ; Romero-Reyes M Br J Pharmacol; 2024 Feb; 181(3):480-494. PubMed ID: 37706270 [TBL] [Abstract][Full Text] [Related]
15. Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation. Hu B; Akerman S; Goadsby PJ Neuropharmacology; 2021 Sep; 195():108375. PubMed ID: 33444636 [TBL] [Abstract][Full Text] [Related]
16. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222 [TBL] [Abstract][Full Text] [Related]
17. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain. Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556 [TBL] [Abstract][Full Text] [Related]
18. Episodic dural stimulation in awake rats: a model for recurrent headache. Oshinsky ML; Gomonchareonsiri S Headache; 2007; 47(7):1026-36. PubMed ID: 17635594 [TBL] [Abstract][Full Text] [Related]
19. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain. Ben Aissa M; Tipton AF; Bertels Z; Gandhi R; Moye LS; Novack M; Bennett BM; Wang Y; Litosh V; Lee SH; Gaisina IN; Thatcher GR; Pradhan AA Cephalalgia; 2018 Jul; 38(8):1471-1484. PubMed ID: 29022756 [TBL] [Abstract][Full Text] [Related]